Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs334

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr11:5227002 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
T>A / T>C / T>G
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.003480 (874/251180, GnomAD_exome)
A=0.012978 (1820/140232, GnomAD)
A=0.004384 (532/121340, ExAC) (+ 10 more)
A=0.00078 (35/44606, ALFA)
A=0.0287 (184/6404, 1000G_30x)
A=0.0274 (137/5008, 1000G)
G=0.0017 (5/2922, KOREAN)
G=0.0005 (1/1832, Korea1K)
A=0.040 (13/322, HapMap)
A=0.019 (4/216, Qatari)
A=0.00 (0/92, Ancient Sardinia)
T=0.5 (5/10, SGDP_PRJ)
A=0.5 (5/10, SGDP_PRJ)
Clinical Significance
Reported in ClinVar
Gene : Consequence
HBB : Missense Variant
Publications
112 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 44606 T=0.99922 A=0.00078 0.998431 0.0 0.001569 0
European Sub 32830 T=0.99994 A=0.00006 0.999878 0.0 0.000122 0
African Sub 3340 T=0.9970 A=0.0030 0.994012 0.0 0.005988 0
African Others Sub 108 T=0.991 A=0.009 0.981481 0.0 0.018519 0
African American Sub 3232 T=0.9972 A=0.0028 0.994431 0.0 0.005569 0
Asian Sub 168 T=1.000 A=0.000 1.0 0.0 0.0 N/A
East Asian Sub 112 T=1.000 A=0.000 1.0 0.0 0.0 N/A
Other Asian Sub 56 T=1.00 A=0.00 1.0 0.0 0.0 N/A
Latin American 1 Sub 498 T=0.978 A=0.022 0.955823 0.0 0.044177 0
Latin American 2 Sub 626 T=1.000 A=0.000 1.0 0.0 0.0 N/A
South Asian Sub 98 T=1.00 A=0.00 1.0 0.0 0.0 N/A
Other Sub 7046 T=0.9983 A=0.0017 0.996594 0.0 0.003406 0


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
gnomAD - Exomes Global Study-wide 251180 T=0.996520 A=0.003480
gnomAD - Exomes European Sub 135172 T=0.999956 A=0.000044
gnomAD - Exomes Asian Sub 48978 T=0.99961 A=0.00039
gnomAD - Exomes American Sub 34570 T=0.99783 A=0.00217
gnomAD - Exomes African Sub 16256 T=0.95300 A=0.04700
gnomAD - Exomes Ashkenazi Jewish Sub 10070 T=1.00000 A=0.00000
gnomAD - Exomes Other Sub 6134 T=0.9984 A=0.0016
gnomAD - Genomes Global Study-wide 140232 T=0.987022 A=0.012978
gnomAD - Genomes European Sub 75944 T=0.99986 A=0.00014
gnomAD - Genomes African Sub 42028 T=0.95915 A=0.04085
gnomAD - Genomes American Sub 13660 T=0.99510 A=0.00490
gnomAD - Genomes Ashkenazi Jewish Sub 3322 T=1.0000 A=0.0000
gnomAD - Genomes East Asian Sub 3130 T=1.0000 A=0.0000
gnomAD - Genomes Other Sub 2148 T=0.9884 A=0.0116
ExAC Global Study-wide 121340 T=0.995616 A=0.004384
ExAC Europe Sub 73348 T=0.99992 A=0.00008
ExAC Asian Sub 25132 T=0.99964 A=0.00036
ExAC American Sub 11548 T=0.99896 A=0.00104
ExAC African Sub 10404 T=0.95146 A=0.04854
ExAC Other Sub 908 T=1.000 A=0.000
Allele Frequency Aggregator Total Global 44606 T=0.99922 A=0.00078
Allele Frequency Aggregator European Sub 32830 T=0.99994 A=0.00006
Allele Frequency Aggregator Other Sub 7046 T=0.9983 A=0.0017
Allele Frequency Aggregator African Sub 3340 T=0.9970 A=0.0030
Allele Frequency Aggregator Latin American 2 Sub 626 T=1.000 A=0.000
Allele Frequency Aggregator Latin American 1 Sub 498 T=0.978 A=0.022
Allele Frequency Aggregator Asian Sub 168 T=1.000 A=0.000
Allele Frequency Aggregator South Asian Sub 98 T=1.00 A=0.00
1000Genomes_30x Global Study-wide 6404 T=0.9713 A=0.0287
1000Genomes_30x African Sub 1786 T=0.8998 A=0.1002
1000Genomes_30x Europe Sub 1266 T=1.0000 A=0.0000
1000Genomes_30x South Asian Sub 1202 T=1.0000 A=0.0000
1000Genomes_30x East Asian Sub 1170 T=1.0000 A=0.0000
1000Genomes_30x American Sub 980 T=0.995 A=0.005
1000Genomes Global Study-wide 5008 T=0.9726 A=0.0274
1000Genomes African Sub 1322 T=0.9002 A=0.0998
1000Genomes East Asian Sub 1008 T=1.0000 A=0.0000
1000Genomes Europe Sub 1006 T=1.0000 A=0.0000
1000Genomes South Asian Sub 978 T=1.000 A=0.000
1000Genomes American Sub 694 T=0.993 A=0.007
KOREAN population from KRGDB KOREAN Study-wide 2922 T=0.9983 G=0.0017
Korean Genome Project KOREAN Study-wide 1832 T=0.9995 G=0.0005
HapMap Global Study-wide 322 T=0.960 A=0.040
HapMap American Sub 118 T=1.000 A=0.000
HapMap African Sub 114 T=0.886 A=0.114
HapMap Asian Sub 90 T=1.00 A=0.00
Qatari Global Study-wide 216 T=0.981 A=0.019
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 92 T=1.00 A=0.00
SGDP_PRJ Global Study-wide 10 T=0.5 A=0.5
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 11 NC_000011.10:g.5227002T>A
GRCh38.p14 chr 11 NC_000011.10:g.5227002T>C
GRCh38.p14 chr 11 NC_000011.10:g.5227002T>G
GRCh37.p13 chr 11 NC_000011.9:g.5248232T>A
GRCh37.p13 chr 11 NC_000011.9:g.5248232T>C
GRCh37.p13 chr 11 NC_000011.9:g.5248232T>G
HBB region RefSeqGene NG_000007.3:g.70614A>T
HBB region RefSeqGene NG_000007.3:g.70614A>G
HBB region RefSeqGene NG_000007.3:g.70614A>C
HBB RefSeqGene (LRG_1232) NG_059281.1:g.5070A>T
HBB RefSeqGene (LRG_1232) NG_059281.1:g.5070A>G
HBB RefSeqGene (LRG_1232) NG_059281.1:g.5070A>C
LOC107133510 genomic region NG_046672.1:g.4937T>A
LOC107133510 genomic region NG_046672.1:g.4937T>C
LOC107133510 genomic region NG_046672.1:g.4937T>G
LOC106099062 genomic region NG_042296.1:g.533T>A
LOC106099062 genomic region NG_042296.1:g.533T>C
LOC106099062 genomic region NG_042296.1:g.533T>G
Gene: HBB, hemoglobin subunit beta (minus strand)
Molecule type Change Amino acid[Codon] SO Term
HBB transcript NM_000518.5:c.20A>T E [GAG] > V [GTG] Coding Sequence Variant
hemoglobin subunit beta NP_000509.1:p.Glu7Val E (Glu) > V (Val) Missense Variant
HBB transcript NM_000518.5:c.20A>G E [GAG] > G [GGG] Coding Sequence Variant
hemoglobin subunit beta NP_000509.1:p.Glu7Gly E (Glu) > G (Gly) Missense Variant
HBB transcript NM_000518.5:c.20A>C E [GAG] > A [GCG] Coding Sequence Variant
hemoglobin subunit beta NP_000509.1:p.Glu7Ala E (Glu) > A (Ala) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 30372 )
ClinVar Accession Disease Names Clinical Significance
RCV000016286.7 HEMOGLOBIN ZIGUINCHOR Other
RCV000016573.14 HEMOGLOBIN S Other
RCV000016574.54 Hb SS disease Pathogenic
RCV000016575.37 Malaria, resistance to Protective
RCV000016576.8 HEMOGLOBIN S (ANTILLES) Pathogenic
RCV000016577.8 Sickle cell-Hemoglobin O Arab disease Pathogenic
RCV000016579.8 HEMOGLOBIN S (PROVIDENCE) Pathogenic
RCV000016580.9 HEMOGLOBIN S (TRAVIS) Pathogenic
RCV000016877.8 HEMOGLOBIN S (CAMEROON) Pathogenic
RCV000016879.5 HEMOGLOBIN JAMAICA PLAIN Other
RCV000030905.6 HEMOGLOBIN ZIGUINCHOR Other
RCV000224000.29 not provided Pathogenic
RCV000477892.3 Dominant beta-thalassemia,Fetal hemoglobin quantitative trait locus 1,Hb SS disease,Heinz body anemia,Malaria, susceptibility to,beta Thalassemia Pathogenic
RCV000576548.11 beta Thalassemia Conflicting-Interpretations-Of-Pathogenicity
RCV000623118.2 Inborn genetic diseases Pathogenic
RCV000723337.4 Fetal hemoglobin quantitative trait locus 1 Likely-Benign
RCV001104054.3 Hemoglobin E Likely-Benign
RCV001192494.2 Sickle cell disease and related diseases Pathogenic
RCV001255121.2 Anemia Pathogenic
RCV001535873.2 Dominant beta-thalassemia,Erythrocytosis, familial, 6,Fetal hemoglobin quantitative trait locus 1,Hb SS disease,Heinz body anemia,Malaria, susceptibility to,Methemoglobinemia, beta-globin type,alpha Thalassemia,beta Thalassemia Pathogenic
RCV001777141.2 not specified Benign
RCV001824571.5 HBB-Related Disorders Pathogenic
RCV002251908.2 See cases Pathogenic
Allele: G (allele ID: 30214 )
ClinVar Accession Disease Names Clinical Significance
RCV000016352.5 HEMOGLOBIN G (MAKASSAR) Other
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement T= A C G
GRCh38.p14 chr 11 NC_000011.10:g.5227002= NC_000011.10:g.5227002T>A NC_000011.10:g.5227002T>C NC_000011.10:g.5227002T>G
GRCh37.p13 chr 11 NC_000011.9:g.5248232= NC_000011.9:g.5248232T>A NC_000011.9:g.5248232T>C NC_000011.9:g.5248232T>G
HBB region RefSeqGene NG_000007.3:g.70614= NG_000007.3:g.70614A>T NG_000007.3:g.70614A>G NG_000007.3:g.70614A>C
HBB RefSeqGene (LRG_1232) NG_059281.1:g.5070= NG_059281.1:g.5070A>T NG_059281.1:g.5070A>G NG_059281.1:g.5070A>C
HBB transcript NM_000518.5:c.20= NM_000518.5:c.20A>T NM_000518.5:c.20A>G NM_000518.5:c.20A>C
HBB transcript NM_000518.4:c.20= NM_000518.4:c.20A>T NM_000518.4:c.20A>G NM_000518.4:c.20A>C
LOC107133510 genomic region NG_046672.1:g.4937= NG_046672.1:g.4937T>A NG_046672.1:g.4937T>C NG_046672.1:g.4937T>G
LOC106099062 genomic region NG_042296.1:g.533= NG_042296.1:g.533T>A NG_042296.1:g.533T>C NG_042296.1:g.533T>G
hemoglobin subunit beta NP_000509.1:p.Glu7= NP_000509.1:p.Glu7Val NP_000509.1:p.Glu7Gly NP_000509.1:p.Glu7Ala
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

57 SubSNP, 12 Frequency, 24 ClinVar submissions
No Submitter Submission ID Date (Build)
1 NCBI ss335 Sep 19, 2000 (36)
2 SEQUENOM ss24811263 Sep 20, 2004 (123)
3 APPLERA_GI ss48419811 Mar 13, 2006 (126)
4 MILLER_NIDDK ss49850538 Mar 13, 2006 (126)
5 MILLER_NIDDK ss49850540 Mar 13, 2006 (126)
6 MILLER_NIDDK ss49850542 Mar 13, 2006 (126)
7 MILLER_NIDDK ss49850544 Mar 13, 2006 (126)
8 MILLER_NIDDK ss49850546 Mar 13, 2006 (126)
9 MILLER_NIDDK ss49850548 Mar 13, 2006 (126)
10 MILLER_NIDDK ss49850550 Mar 13, 2006 (126)
11 MILLER_NIDDK ss49850552 Mar 13, 2006 (126)
12 MILLER_NIDDK ss49850554 Mar 13, 2006 (126)
13 MILLER_NIDDK ss49850555 Mar 13, 2006 (126)
14 MILLER_NIDDK ss65658196 Dec 01, 2006 (127)
15 PERLEGEN ss69307501 May 17, 2007 (127)
16 HBVAR ss79088884 Oct 02, 2012 (137)
17 HBVAR ss79088886 Oct 02, 2012 (137)
18 HBVAR ss79089796 Oct 02, 2012 (137)
19 SEATTLESEQ ss159722269 Dec 01, 2009 (136)
20 COMPLETE_GENOMICS ss168938347 Jul 04, 2010 (136)
21 RSG_UW ss212960460 Jul 04, 2010 (136)
22 1000GENOMES ss225064977 Jul 14, 2010 (136)
23 OMIM-CURATED-RECORDS ss263198838 Nov 08, 2010 (136)
24 OMIM-CURATED-RECORDS ss263198960 Nov 08, 2010 (136)
25 NHLBI-ESP ss342316075 May 09, 2011 (136)
26 1000GENOMES ss491010799 May 04, 2012 (136)
27 EXOME_CHIP ss491445404 May 04, 2012 (136)
28 CLINSEQ_SNP ss491638176 May 04, 2012 (136)
29 ILLUMINA ss533576724 Sep 08, 2015 (146)
30 JMKIDD_LAB ss1067519460 Aug 21, 2014 (142)
31 JMKIDD_LAB ss1077464818 Aug 21, 2014 (142)
32 1000GENOMES ss1339939582 Aug 21, 2014 (142)
33 EVA_EXAC ss1690220976 Apr 01, 2015 (144)
34 ITMI ss1776567973 Sep 08, 2015 (146)
35 WEILL_CORNELL_DGM ss1931523242 Feb 12, 2016 (147)
36 HUMAN_LONGEVITY ss2179830167 Dec 20, 2016 (150)
37 GNOMAD ss2738739466 Nov 08, 2017 (151)
38 GNOMAD ss2748543909 Nov 08, 2017 (151)
39 GNOMAD ss2895840074 Nov 08, 2017 (151)
40 AFFY ss2984931974 Nov 08, 2017 (151)
41 ILLUMINA ss3626587887 Oct 12, 2018 (152)
42 ILLUMINA ss3653703559 Oct 12, 2018 (152)
43 KHV_HUMAN_GENOMES ss3814235341 Jul 13, 2019 (153)
44 EVA ss3824585932 Apr 26, 2020 (154)
45 SGDP_PRJ ss3875552707 Apr 26, 2020 (154)
46 KRGDB ss3923775569 Apr 26, 2020 (154)
47 KOGIC ss3969119145 Apr 26, 2020 (154)
48 FSA-LAB ss3983994691 Apr 26, 2021 (155)
49 EVA ss3985514791 Apr 26, 2021 (155)
50 EVA ss3986512434 Apr 26, 2021 (155)
51 1000G_HIGH_COVERAGE ss5286250469 Oct 16, 2022 (156)
52 EVA ss5397462506 Oct 16, 2022 (156)
53 HUGCELL_USP ss5481570498 Oct 16, 2022 (156)
54 1000G_HIGH_COVERAGE ss5581295063 Oct 16, 2022 (156)
55 SANFORD_IMAGENETICS ss5650547108 Oct 16, 2022 (156)
56 EVA ss5918652479 Oct 16, 2022 (156)
57 EVA ss5941850074 Oct 16, 2022 (156)
58 1000Genomes NC_000011.9 - 5248232 Oct 12, 2018 (152)
59 1000Genomes_30x NC_000011.10 - 5227002 Oct 16, 2022 (156)
60 ExAC NC_000011.9 - 5248232 Oct 12, 2018 (152)
61 gnomAD - Genomes NC_000011.10 - 5227002 Apr 26, 2021 (155)
62 gnomAD - Exomes NC_000011.9 - 5248232 Jul 13, 2019 (153)
63 HapMap NC_000011.10 - 5227002 Apr 26, 2020 (154)
64 KOREAN population from KRGDB NC_000011.9 - 5248232 Apr 26, 2020 (154)
65 Korean Genome Project NC_000011.10 - 5227002 Apr 26, 2020 (154)
66 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000011.9 - 5248232 Apr 26, 2021 (155)
67 Qatari NC_000011.9 - 5248232 Apr 26, 2020 (154)
68 SGDP_PRJ NC_000011.9 - 5248232 Apr 26, 2020 (154)
69 ALFA NC_000011.10 - 5227002 Apr 26, 2021 (155)
70 ClinVar RCV000016286.7 Oct 16, 2022 (156)
71 ClinVar RCV000016352.5 Oct 16, 2022 (156)
72 ClinVar RCV000016573.14 Oct 16, 2022 (156)
73 ClinVar RCV000016574.54 Oct 16, 2022 (156)
74 ClinVar RCV000016575.37 Oct 16, 2022 (156)
75 ClinVar RCV000016576.8 Oct 16, 2022 (156)
76 ClinVar RCV000016577.8 Oct 16, 2022 (156)
77 ClinVar RCV000016579.8 Oct 16, 2022 (156)
78 ClinVar RCV000016580.9 Oct 16, 2022 (156)
79 ClinVar RCV000016877.8 Oct 16, 2022 (156)
80 ClinVar RCV000016879.5 Oct 16, 2022 (156)
81 ClinVar RCV000030905.6 Oct 16, 2022 (156)
82 ClinVar RCV000224000.29 Oct 16, 2022 (156)
83 ClinVar RCV000477892.3 Oct 16, 2022 (156)
84 ClinVar RCV000576548.11 Oct 16, 2022 (156)
85 ClinVar RCV000623118.2 Oct 16, 2022 (156)
86 ClinVar RCV000723337.4 Oct 16, 2022 (156)
87 ClinVar RCV001104054.3 Oct 16, 2022 (156)
88 ClinVar RCV001192494.2 Oct 16, 2022 (156)
89 ClinVar RCV001255121.2 Oct 16, 2022 (156)
90 ClinVar RCV001535873.2 Oct 16, 2022 (156)
91 ClinVar RCV001777141.2 Oct 16, 2022 (156)
92 ClinVar RCV001824571.5 Oct 16, 2022 (156)
93 ClinVar RCV002251908.2 Oct 16, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs3168321 Jul 03, 2002 (106)
rs34315575 Oct 16, 2006 (127)
rs77121243 Oct 09, 2012 (136)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss168938347, ss491638176 NC_000011.8:5204807:T:A NC_000011.10:5227001:T:A (self)
52416096, 466252, 7946312, 740718, 13565172, 27569687, ss225064977, ss342316075, ss491010799, ss491445404, ss533576724, ss1067519460, ss1077464818, ss1339939582, ss1690220976, ss1776567973, ss1931523242, ss2738739466, ss2748543909, ss2895840074, ss2984931974, ss3626587887, ss3653703559, ss3824585932, ss3875552707, ss3983994691, ss3985514791, ss3986512434, ss5397462506, ss5650547108, ss5941850074 NC_000011.9:5248231:T:A NC_000011.10:5227001:T:A (self)
RCV000016286.7, RCV000016573.14, RCV000016574.54, RCV000016575.37, RCV000016576.8, RCV000016577.8, RCV000016579.8, RCV000016580.9, RCV000016877.8, RCV000016879.5, RCV000030905.6, RCV000224000.29, RCV000477892.3, RCV000576548.11, RCV000623118.2, RCV000723337.4, RCV001104054.3, RCV001192494.2, RCV001255121.2, RCV001535873.2, RCV001777141.2, RCV001824571.5, RCV002251908.2, 68820998, 370114569, 538318, 13786692793, ss79088884, ss263198960, ss2179830167, ss3814235341, ss5286250469, ss5481570498, ss5581295063, ss5918652479 NC_000011.10:5227001:T:A NC_000011.10:5227001:T:A (self)
ss335, ss24811263, ss48419811, ss49850538, ss49850540, ss49850542, ss49850544, ss49850546, ss49850548, ss49850550, ss49850552, ss49850555, ss65658196, ss69307501, ss159722269, ss212960460 NT_009237.18:5188231:T:A NC_000011.10:5227001:T:A (self)
ss79089796 NC_000011.10:5227001:T:C NC_000011.10:5227001:T:C (self)
30952963, ss3923775569 NC_000011.9:5248231:T:G NC_000011.10:5227001:T:G (self)
RCV000016352.5, 25497146, ss79088886, ss263198838, ss3969119145 NC_000011.10:5227001:T:G NC_000011.10:5227001:T:G (self)
ss49850554 NT_009237.18:5188231:T:G NC_000011.10:5227001:T:G (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

112 citations for rs334
PMID Title Author Year Journal
81926 Antenatal diagnosis of sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells. Kan YW et al. 1978 Lancet (London, England)
893143 Properties of the double substituted hemoglobin C Ziguinchor alpha2A beta 2 6 Glu replaced by Val 58 Pro replaced by Arg. Hassan W et al. 1977 Hemoglobin
909565 Identification of a nondeletion defect in alpha-thalassemia. Kan YW et al. 1977 The New England journal of medicine
1225575 Hemoglobin C Ziguinchor alphaA2 beta62 (A3) Glu leads to Val beta58 (E2) Pro leads to Arg: the second sickling variant with amino acid substitutions in 2 residues of the beta polypeptide chain. Goossens M et al. 1975 FEBS letters
1301203 Trapped-oligonucleotide nucleotide incorporation (TONI) assay, a simple method for screening point mutations. Prezant TR et al. 1992 Human mutation
1376298 A novel sickle cell mutation of yet another origin in Africa: the Cameroon type. Lapouméroulie C et al. 1992 Human genetics
1634360 Hb Rancho Mirage [beta 143(H21)His----Asp]; a variant in the 2,3-DPG binding site showing normal oxygen affinity at physiological pH. Moo-Penn WF et al. 1992 Hemoglobin
1986365 Genetic disease detection and DNA amplification using cloned thermostable ligase. Barany F et al. 1991 Proceedings of the National Academy of Sciences of the United States of America
2189492 Haemoglobin alpha 2 beta 2 23Val----Ile produced in Escherichia coli facilitates Hb S polymerization. Pagnier J et al. 1990 British journal of haematology
2296310 A transgenic mouse model of sickle cell disorder. Greaves DR et al. 1990 Nature
2579336 Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. Nagel RL et al. 1985 The New England journal of medicine
2891298 Globin gene-associated restriction-fragment-length polymorphisms in southern African peoples. Ramsay M et al. 1987 American journal of human genetics
2893541 Beta S gene in Sicily is in linkage disequilibrium with the Benin haplotype: implications for gene flow. Ragusa A et al. 1988 American journal of hematology
2898142 Structural analysis of the 5' flanking region of the beta-globin gene in African sickle cell anemia patients: further evidence for three origins of the sickle cell mutation in Africa. Chebloune Y et al. 1988 Proceedings of the National Academy of Sciences of the United States of America
2898460 Evidence of the African origin of sickle cell hemoglobin in western Sicily. Sammarco P et al. 1988 Hemoglobin
2930724 A new doubly substituted sickling haemoglobin: HbS-Oman. Langdown JV et al. 1989 British journal of haematology
3048433 Molecular basis and prenatal diagnosis of beta-thalassemia. Kazazian HH Jr et al. 1988 Blood
3191036 Hb A-like sickle haemoglobin: Hb S-providence. Gale RE et al. 1988 British journal of haematology
3354556 Sickle cell trait in a white Jewish family presenting as splenic infarction at high altitude. Shalev O et al. 1988 American journal of hematology
3467311 Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Monplaisir N et al. 1986 Proceedings of the National Academy of Sciences of the United States of America
3690667 Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Grosveld F et al. 1987 Cell
3752087 Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Kulozik AE et al. 1986 American journal of human genetics
3821796 Rapid prenatal diagnosis of sickle cell anemia by a new method of DNA analysis. Embury SH et al. 1987 The New England journal of medicine
4232783 Relatively benign sickle-cell anaemia in 60 patients aged over 30 in the West Indies. Serjeant GR et al. 1968 British medical journal
5069596 Identification of haemoglobin C Georgetown. Lang A et al. 1972 Biochimica et biophysica acta
5490239 The effect of beta 73 Asn on the interactions of sickling hemoglobins. Bookchin RM et al. 1970 Biochimica et biophysica acta
5509617 Hemoglobin G Makassar: beta-6 Glu leads to Ala. Blackwell RQ et al. 1970 Biochimica et biophysica acta
5658717 Hemoglobin variant common to Chinese and North American Indians: alpha-2-beta-22 Glu-Ala. Blackwell RW et al. 1968 Science (New York, N.Y.)
5928902 Hemoglobin C Harlem: a sickling variant containing amino acid substitutions in two residues of the beta-polypeptide chain. Bookchin RM et al. 1966 Biochemical and biophysical research communications
6166632 Molecular analysis of the beta-thalassemia phenotype associated with inheritance of hemoglobin E (alpha 2 beta2(26)Glu leads to Lys). Benz EJ Jr et al. 1981 The Journal of clinical investigation
6268660 Sickle gene. Its origin and diffusion from West Africa. Mears JG et al. 1981 The Journal of clinical investigation
6272289 Direct identification of sickle cell anemia by blot hybridization. Geever RF et al. 1981 Proceedings of the National Academy of Sciences of the United States of America
6280057 Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Orkin SH et al. 1982 Nature
6285354 Use of restriction endonucleases for mapping the allele for beta s-globin. Wilson JT et al. 1982 Proceedings of the National Academy of Sciences of the United States of America
6583683 Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both. Antonarakis SE et al. 1984 Proceedings of the National Academy of Sciences of the United States of America
6584911 Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Pagnier J et al. 1984 Proceedings of the National Academy of Sciences of the United States of America
7993409 Mortality in sickle cell disease. Life expectancy and risk factors for early death. Platt OS et al. 1994 The New England journal of medicine
8199597 Sequence of the -530 region of the beta-globin gene of sickle cell anemia patients with the Arabian haplotype. Zeng FY et al. 1994 Human mutation
8462981 Why are some genetic diseases common? Distinguishing selection from other processes by molecular analysis of globin gene variants. Flint J et al. 1993 Human genetics
9166865 A transgenic mouse model of hemoglobin S Antilles disease. Popp RA et al. 1997 Blood
9834244 HbS-oman heterozygote: a new dominant sickle syndrome. Nagel RL et al. 1998 Blood
9859938 Hb Köln [beta98(FG5)Val-->Met]: the first case found in a Chinese family. Chang JG et al. 1998 Hemoglobin
10203101 Hemoglobin S/O(Arab): thirteen new cases and review of the literature. Zimmerman SA et al. 1999 American journal of hematology
11741197 Molecular analysis of the beta-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the beta(S) Senegal mutation. Currat M et al. 2002 American journal of human genetics
11830454 Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Romero JR et al. 2002 Blood
11880644 Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Turhan A et al. 2002 Proceedings of the National Academy of Sciences of the United States of America
12403489 Hb G-Makassar [beta6(A3)Glu-->Ala; codon 6 (GAG-->GCG)]: molecular characterization, clinical, and hematological effects. Viprakasit V et al. 2002 Hemoglobin
13066514 Further studies on hemoglobin C. I. A description of three additional families segregating for hemoglobin C and sickle cell hemoglobin. NEEL JV et al. 1953 Blood
13115700 Protection afforded by sickle-cell trait against subtertian malareal infection. ALLISON AC et al. 1954 British medical journal
13369537 A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. INGRAM VM et al. 1956 Nature
13464827 Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. INGRAM VM et al. 1957 Nature
13852872 Abnormal human haemoglobins. III. The chemical difference between normal and sickle cell haemoglobins. INGRAM VM et al. 1959 Biochimica et biophysica acta
13943409 A new hemoglobin variant with sickling properties. PIERCE LE et al. 1963 The New England journal of medicine
15182055 A new variant with two amino acid substitutions: Hb S-Cameroon [beta6(A3)Glu-->Val;beta90(F6)Glu-->Lys]. Bundgaard JR et al. 2004 Hemoglobin
15395398 Sickle cell anemia a molecular disease. PAULING L et al. 1949 Science (New York, N.Y.)
15470216 Hemoglobin Jamaica plain--a sickling hemoglobin with reduced oxygen affinity. Geva A et al. 2004 The New England journal of medicine
16001361 How malaria has affected the human genome and what human genetics can teach us about malaria. Kwiatkowski DP et al. 2005 American journal of human genetics
17287491 Elderly survivors with homozygous sickle cell disease. Serjeant GR et al. 2007 The New England journal of medicine
17668374 Combining evidence of natural selection with association analysis increases power to detect malaria-resistance variants. Ayodo G et al. 2007 American journal of human genetics
17688704 Classical sickle beta-globin haplotypes exhibit a high degree of long-range haplotype similarity in African and Afro-Caribbean populations. Hanchard N et al. 2007 BMC genetics
18048408 Haemoglobin S and haemoglobin C: 'quick but costly' versus 'slow but gratis' genetic adaptations to Plasmodium falciparum malaria. Modiano D et al. 2008 Human molecular genetics
18192399 Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Cholera R et al. 2008 Proceedings of the National Academy of Sciences of the United States of America
18829352 High-density SNP genotyping to define beta-globin locus haplotypes. Liu L et al. 2009 Blood cells, molecules & diseases
19039607 A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Diakite M et al. 2009 Human genetics
19145247 Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations. Mangano VD et al. 2009 PloS one
19223928 Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Clark TG et al. 2009 European journal of human genetics
19281305 Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations. Clark TG et al. 2009 The Journal of infectious diseases
19465909 Genome-wide and fine-resolution association analysis of malaria in West Africa. Jallow M et al. 2009 Nature genetics
20128890 Loss of balancing selection in the betaS globin locus. Salih NA et al. 2010 BMC medical genetics
20226094 Myosin individualized: single nucleotide polymorphisms in energy transduction. Burghardt TP et al. 2010 BMC genomics
20305663 Genetic variation in human HBB is associated with Plasmodium falciparum transmission. Gouagna LC et al. 2010 Nature genetics
20552021 Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children. Savy M et al. 2010 PloS one
20556870 CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Johnson AD et al. 2010 Genetics in medicine
20585394 Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. Sambo MR et al. 2010 PloS one
21529713 Sickle hemoglobin confers tolerance to Plasmodium infection. Ferreira A et al. 2011 Cell
21867552 Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites. Diakite M et al. 2011 Malaria journal
21992066 Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers. Thomas PE et al. 2011 BMC bioinformatics
22075726 Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes. Cyrklaff M et al. 2011 Science (New York, N.Y.)
22615793 Investigation of host candidate malaria-associated risk/protective SNPs in a Brazilian Amazonian population. da Silva Santos S et al. 2012 PloS one
22905743 Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka. Dewasurendra RL et al. 2012 Malaria journal
22947458 Malaria resistance genes are associated with the levels of IgG subclasses directed against Plasmodium falciparum blood-stage antigens in Burkina Faso. Afridi S et al. 2012 Malaria journal
22957039 Candidate polymorphisms and severe malaria in a Malian population. Toure O et al. 2012 PloS one
23144702 Candidate human genetic polymorphisms and severe malaria in a Tanzanian population. Manjurano A et al. 2012 PloS one
23316245 The host genetic diversity in malaria infection. de Mendonça VR et al. 2012 Journal of tropical medicine
24592274 Genomic architecture of sickle cell disease in West African children. Quinlan J et al. 2014 Frontiers in genetics
24626632 Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage. Barfield WL et al. 2014 Human molecular genetics
24934404 Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study. Apinjoh TO et al. 2014 Malaria journal
25741868 Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Richards S et al. 2015 Genetics in medicine
25805752 USP38, FREM3, SDC1, DDC, and LOC727982 Gene Polymorphisms and Differential Susceptibility to Severe Malaria in Tanzania. Manjurano A et al. 2015 The Journal of infectious diseases
26215182 The influence of host genetics on erythrocytes and malaria infection: is there therapeutic potential? Lelliott PM et al. 2015 Malaria journal
26314886 Genetic determinants of anti-malarial acquired immunity in a large multi-centre study. Shelton JM et al. 2015 Malaria journal
26744416 Environmental Correlation Analysis for Genes Associated with Protection against Malaria. Mackinnon MJ et al. 2016 Molecular biology and evolution
27022141 Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease. Liu L et al. 2016 Experimental biology and medicine (Maywood, N.J.)
27185208 Homozygosity for a haplotype in the HBG2-OR51B4 region is exclusive to Arab-Indian haplotype sickle cell anemia. Vathipadiekal V et al. 2016 American journal of hematology
27219052 Global Carrier Rates of Rare Inherited Disorders Using Population Exome Sequences. Fujikura K et al. 2016 PloS one
27236921 Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children. Rautanen A et al. 2016 American journal of human genetics
27351925 Development of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean Populations. Chassanidis C et al. 2016 PloS one
28067620 Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia. Clarke GM et al. 2017 eLife
28912365 D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study. Raffield LM et al. 2017 Arteriosclerosis, thrombosis, and vascular biology
29526279 Whole-Genome-Sequence-Based Haplotypes Reveal Single Origin of the Sickle Allele during the Holocene Wet Phase. Shriner D et al. 2018 American journal of human genetics
31080455 Complimentary Methods for Multivariate Genome-Wide Association Study Identify New Susceptibility Genes for Blood Cell Traits. Fatumo S et al. 2019 Frontiers in genetics
31213470 A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A(1c) With Implications for Glycemic Status in U.S. Hispanics/Latinos. Moon JY et al. 2019 Diabetes care
31448710 Frequency of Interleukins IL1ß/IL18 and Inflammasome NLRP1/NLRP3 Polymorphisms in Sickle Cell Anemia Patients and their Association with Severity Score. de Almeida E et al. 2019 Current molecular medicine
31675503 Uganda Genome Resource Enables Insights into Population History and Genomic Discovery in Africa. Gurdasani D et al. 2019 Cell
31941490 Associations between red blood cell variants and malaria among children and adults from three areas of Uganda: a prospective cohort study. Kakande E et al. 2020 Malaria journal
32641076 Exome sequencing for diagnosis of congenital hemolytic anemia. Mansour-Hendili L et al. 2020 Orphanet journal of rare diseases
33357513 Host genetic effects in pneumonia. Chen HH et al. 2021 American journal of human genetics
33399855 Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals. Hyacinth HI et al. 2021 JAMA network open
33857205 Use of amplicon-based sequencing for testing fetal identity and monogenic traits with Single Circulating Trophoblast (SCT) as one form of cell-based NIPT. Zhuo X et al. 2021 PloS one
34090531 Genome-based therapeutic interventions for β-type hemoglobinopathies. Karamperis K et al. 2021 Human genomics
35811813 G6PD and HBB polymorphisms in the Senegalese population: prevalence, correlation with clinical malaria. Thiam F et al. 2022 PeerJ
35934714 Risk score prediction model based on single nucleotide polymorphism for predicting malaria: a machine learning approach. Tai KY et al. 2022 BMC bioinformatics
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post820+afb47a3d